25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Next Science Ltd
Buy, Hold or Sell?

Let's analyze Next Science Ltd together

I guess you are interested in Next Science Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Next Science Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Next Science Ltd

I send you an email if I find something interesting about Next Science Ltd.

Quick analysis of Next Science Ltd (30 sec.)










What can you expect buying and holding a share of Next Science Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
A$0.10
Expected worth in 1 year
A$0.24
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$0.15
Return On Investment
52.8%

For what price can you sell your share?

Current Price per Share
A$0.28
Expected price per share
A$0.18 - A$0.31
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Next Science Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.28

Intrinsic Value Per Share

A$-1.08 - A$-1.09

Total Value Per Share

A$-0.98 - A$-0.99

2. Growth of Next Science Ltd (5 min.)




Is Next Science Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$18.7m$11.8m$6.9m36.9%

How much money is Next Science Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$24.5m-$18.2m-$6.2m-25.4%
Net Profit Margin-73.4%-108.3%--

How much money comes from the company's main activities?

3. Financial Health of Next Science Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Next Science Ltd? (5 min.)

Welcome investor! Next Science Ltd's management wants to use your money to grow the business. In return you get a share of Next Science Ltd.

What can you expect buying and holding a share of Next Science Ltd?

First you should know what it really means to hold a share of Next Science Ltd. And how you can make/lose money.

Speculation

The Price per Share of Next Science Ltd is A$0.275. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Next Science Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Next Science Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.10. Based on the TTM, the Book Value Change Per Share is A$0.04 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Next Science Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.08-30.6%-0.08-30.6%-0.04-15.8%-0.05-18.2%-0.04-14.3%
Usd Book Value Change Per Share0.028.7%0.028.7%-0.01-3.7%-0.01-3.0%0.012.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.5%0.000.3%
Usd Total Gains Per Share0.028.7%0.028.7%-0.01-3.7%-0.01-2.5%0.013.2%
Usd Price Per Share0.22-0.22-0.45-0.71-0.44-
Price to Earnings Ratio-2.65--2.65--10.32--16.70--10.44-
Price-to-Total Gains Ratio9.36-9.36--44.24--86.42--86.42-
Price to Book Ratio3.46-3.46-11.05-10.67-6.67-
Price-to-Total Gains Ratio9.36-9.36--44.24--86.42--86.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1801525
Number of shares5550
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.02-0.01
Usd Total Gains Per Share0.02-0.01
Gains per Quarter (5550 shares)132.05-37.97
Gains per Year (5550 shares)528.19-151.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1052851829-181-162
201056104659-362-314
301585157488-544-466
4021132102117-725-618
5026412630147-906-770
6031693158176-1087-922
7036973686205-1269-1074
8042264214235-1450-1226
9047544742264-1631-1378
10052825270294-1812-1530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%4.04.00.050.0%4.04.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.07.012.5%1.00.07.012.5%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%4.04.00.050.0%4.04.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Next Science Ltd

About Next Science Ltd

Next Science Limited engages in the research, development, and commercialization of technologies that address the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial gel that conforms to the postoperative wound; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-07-09 01:45:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Next Science Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Next Science Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -73.4% means that $-0.73 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Next Science Ltd:

  • The MRQ is -73.4%. The company is making a huge loss. -2
  • The TTM is -73.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-73.4%TTM-73.4%0.0%
TTM-73.4%YOY-108.3%+34.9%
TTM-73.4%5Y-197.1%+123.8%
5Y-197.1%10Y-543.5%+346.4%
1.1.2. Return on Assets

Shows how efficient Next Science Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -93.4% Return on Assets means that Next Science Ltd generated $-0.93 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Next Science Ltd:

  • The MRQ is -93.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -93.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-93.4%TTM-93.4%0.0%
TTM-93.4%YOY-99.6%+6.1%
TTM-93.4%5Y-75.9%-17.5%
5Y-75.9%10Y-73.6%-2.3%
1.1.3. Return on Equity

Shows how efficient Next Science Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -130.5% Return on Equity means Next Science Ltd generated $-1.30 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Next Science Ltd:

  • The MRQ is -130.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -130.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-130.5%TTM-130.5%0.0%
TTM-130.5%YOY-154.4%+23.9%
TTM-130.5%5Y-102.9%-27.6%
5Y-102.9%10Y-94.8%-8.1%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Next Science Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Next Science Ltd is operating .

  • Measures how much profit Next Science Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -72.3% means the company generated $-0.72  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Next Science Ltd:

  • The MRQ is -72.3%. The company is operating very inefficient. -2
  • The TTM is -72.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-72.3%TTM-72.3%0.0%
TTM-72.3%YOY-108.4%+36.1%
TTM-72.3%5Y-192.2%+119.9%
5Y-192.2%10Y-639.8%+447.6%
1.2.2. Operating Ratio

Measures how efficient Next Science Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.72 means that the operating costs are $1.72 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Next Science Ltd:

  • The MRQ is 1.723. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.723. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.723TTM1.7230.000
TTM1.723YOY2.084-0.361
TTM1.7235Y2.922-1.199
5Y2.92210Y7.273-4.351
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Next Science Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Next Science Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.64 means the company has $3.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Next Science Ltd:

  • The MRQ is 3.639. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.639. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.639TTM3.6390.000
TTM3.639YOY3.170+0.469
TTM3.6395Y6.191-2.552
5Y6.19110Y7.679-1.488
1.3.2. Quick Ratio

Measures if Next Science Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.36 means the company can pay off $3.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Next Science Ltd:

  • The MRQ is 3.363. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.363. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.363TTM3.3630.000
TTM3.363YOY2.642+0.721
TTM3.3635Y6.091-2.727
5Y6.09110Y7.433-1.343
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Next Science Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Next Science Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Next Science Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.28 means that Next Science Ltd assets are financed with 28.4% credit (debt) and the remaining percentage (100% - 28.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Next Science Ltd:

  • The MRQ is 0.284. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.284. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.284TTM0.2840.000
TTM0.284YOY0.355-0.071
TTM0.2845Y0.240+0.044
5Y0.24010Y0.198+0.042
1.4.2. Debt to Equity Ratio

Measures if Next Science Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 39.6% means that company has $0.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Next Science Ltd:

  • The MRQ is 0.396. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.396. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.396TTM0.3960.000
TTM0.396YOY0.551-0.154
TTM0.3965Y0.329+0.068
5Y0.32910Y0.261+0.068
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Next Science Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Next Science Ltd generates.

  • Above 15 is considered overpriced but always compare Next Science Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -2.65 means the investor is paying $-2.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Next Science Ltd:

  • The EOD is -2.144. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.650. Based on the earnings, the company is expensive. -2
  • The TTM is -2.650. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.144MRQ-2.650+0.507
MRQ-2.650TTM-2.6500.000
TTM-2.650YOY-10.320+7.670
TTM-2.6505Y-16.700+14.049
5Y-16.70010Y-10.437-6.262
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Next Science Ltd:

  • The EOD is -2.188. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.705. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.705. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.188MRQ-2.705+0.517
MRQ-2.705TTM-2.7050.000
TTM-2.705YOY-7.398+4.693
TTM-2.7055Y-12.190+9.486
5Y-12.19010Y-7.619-4.571
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Next Science Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Next Science Ltd:

  • The EOD is 2.797. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.458. Based on the equity, the company is fair priced.
  • The TTM is 3.458. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.797MRQ3.458-0.661
MRQ3.458TTM3.4580.000
TTM3.458YOY11.046-7.589
TTM3.4585Y10.671-7.214
5Y10.67110Y6.670+4.002
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Next Science Ltd.

3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Next Science Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0360.0360%-0.015+143%-0.012+134%0.012+195%
Book Value Per Share--0.0980.0980%0.062+59%0.102-4%0.088+12%
Current Ratio--3.6393.6390%3.170+15%6.191-41%7.679-53%
Debt To Asset Ratio--0.2840.2840%0.355-20%0.240+18%0.198+43%
Debt To Equity Ratio--0.3960.3960%0.551-28%0.329+21%0.261+52%
Dividend Per Share----0%-0%0.002-100%0.001-100%
Eps---0.128-0.1280%-0.066-48%-0.076-41%-0.060-53%
Free Cash Flow Per Share---0.126-0.1260%-0.093-26%-0.096-23%-0.074-41%
Free Cash Flow To Equity Per Share--0.0330.0330%-0.015+146%0.005+584%0.008+287%
Gross Profit Margin--1.8231.8230%1.564+17%1.468+24%1.292+41%
Intrinsic Value_10Y_max---1.086--------
Intrinsic Value_10Y_min---1.078--------
Intrinsic Value_1Y_max---0.097--------
Intrinsic Value_1Y_min---0.100--------
Intrinsic Value_3Y_max---0.301--------
Intrinsic Value_3Y_min---0.310--------
Intrinsic Value_5Y_max---0.515--------
Intrinsic Value_5Y_min---0.527--------
Market Cap80216127.200-24%99176302.72099176302.7200%199811080.480-50%315030608.640-69%196894130.400-50%
Net Profit Margin---0.734-0.7340%-1.083+48%-1.971+169%-5.435+641%
Operating Margin---0.723-0.7230%-1.084+50%-1.922+166%-6.398+785%
Operating Ratio--1.7231.7230%2.084-17%2.922-41%7.273-76%
Pb Ratio2.797-24%3.4583.4580%11.046-69%10.671-68%6.670-48%
Pe Ratio-2.144+19%-2.650-2.6500%-10.320+289%-16.700+530%-10.437+294%
Price Per Share0.275-24%0.3400.3400%0.685-50%1.080-69%0.675-50%
Price To Free Cash Flow Ratio-2.188+19%-2.705-2.7050%-7.398+174%-12.190+351%-7.619+182%
Price To Total Gains Ratio7.572-24%9.3629.3620%-44.236+573%-86.425+1023%-86.425+1023%
Quick Ratio--3.3633.3630%2.642+27%6.091-45%7.433-55%
Return On Assets---0.934-0.9340%-0.996+7%-0.759-19%-0.736-21%
Return On Equity---1.305-1.3050%-1.544+18%-1.029-21%-0.948-27%
Total Gains Per Share--0.0360.0360%-0.015+143%-0.010+129%0.014+168%
Usd Book Value--18789750.71418789750.7140%11849600.272+59%19500856.732-4%16843663.211+12%
Usd Book Value Change Per Share--0.0240.0240%-0.010+143%-0.008+134%0.008+195%
Usd Book Value Per Share--0.0640.0640%0.041+59%0.067-4%0.058+12%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps---0.084-0.0840%-0.043-48%-0.050-41%-0.039-53%
Usd Free Cash Flow---24019941.800-24019941.8000%-17693384.586-26%-18406210.421-23%-14213753.268-41%
Usd Free Cash Flow Per Share---0.082-0.0820%-0.061-26%-0.063-23%-0.049-41%
Usd Free Cash Flow To Equity Per Share--0.0220.0220%-0.010+146%0.003+584%0.006+287%
Usd Market Cap52549584.929-24%64970395.91264970395.9120%130896238.822-50%206376551.720-69%128985344.825-50%
Usd Price Per Share0.180-24%0.2230.2230%0.449-50%0.708-69%0.442-50%
Usd Profit---24513116.806-24513116.8060%-18296113.704-25%-18644265.637-24%-14386389.395-41%
Usd Revenue--33414704.15633414704.1560%16896003.493+98%14614719.538+129%9676169.462+245%
Usd Total Gains Per Share--0.0240.0240%-0.010+143%-0.007+129%0.009+168%
 EOD+2 -6MRQTTM+0 -0YOY+23 -115Y+14 -2210Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Next Science Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.144
Price to Book Ratio (EOD)Between0-12.797
Net Profit Margin (MRQ)Greater than0-0.734
Operating Margin (MRQ)Greater than0-0.723
Quick Ratio (MRQ)Greater than13.363
Current Ratio (MRQ)Greater than13.639
Debt to Asset Ratio (MRQ)Less than10.284
Debt to Equity Ratio (MRQ)Less than10.396
Return on Equity (MRQ)Greater than0.15-1.305
Return on Assets (MRQ)Greater than0.05-0.934
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Next Science Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.954
Ma 20Greater thanMa 500.245
Ma 50Greater thanMa 1000.254
Ma 100Greater thanMa 2000.309
OpenGreater thanClose0.285
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets26,233
Total Liabilities7,444
Total Stockholder Equity18,790
 As reported
Total Liabilities 7,444
Total Stockholder Equity+ 18,790
Total Assets = 26,233

Assets

Total Assets26,233
Total Current Assets20,459
Long-term Assets5,774
Total Current Assets
Cash And Cash Equivalents 13,540
Short-term Investments 55
Net Receivables 5,259
Inventory 1,057
Other Current Assets 548
Total Current Assets  (as reported)20,459
Total Current Assets  (calculated)20,459
+/- 0
Long-term Assets
Property Plant Equipment 2,222
Intangible Assets 2,387
Long-term Assets Other 1,165
Long-term Assets  (as reported)5,774
Long-term Assets  (calculated)5,774
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,623
Long-term Liabilities1,821
Total Stockholder Equity18,790
Total Current Liabilities
Short-term Debt 403
Accounts payable 2,068
Other Current Liabilities 2,749
Total Current Liabilities  (as reported)5,623
Total Current Liabilities  (calculated)5,220
+/- 403
Long-term Liabilities
Capital Lease Obligations 962
Long-term Liabilities  (as reported)1,821
Long-term Liabilities  (calculated)962
+/- 859
Total Stockholder Equity
Common Stock196,122
Retained Earnings -115,060
Accumulated Other Comprehensive Income -62,272
Other Stockholders Equity 0
Total Stockholder Equity (as reported)18,790
Total Stockholder Equity (calculated)18,790
+/-0
Other
Capital Stock133,824
Cash and Short Term Investments 13,595
Common Stock Shares Outstanding 234,095
Current Deferred Revenue403
Liabilities and Stockholders Equity 26,233
Net Debt -12,130
Net Invested Capital 12,821
Net Working Capital 10,124
Property Plant and Equipment Gross 3,808
Short Long Term Debt Total 1,410



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
2,206
5,414
33,853
32,292
30,634
18,867
18,373
26,233
26,23318,37318,86730,63432,29233,8535,4142,206
   > Total Current Assets 
1,279
3,798
31,907
27,433
26,245
14,073
12,185
20,459
20,45912,18514,07326,24527,43331,9073,7981,279
       Cash And Cash Equivalents 
1,096
3,321
30,600
24,057
10,498
9,629
7,482
13,540
13,5407,4829,62910,49824,05730,6003,3211,096
       Short-term Investments 
0
0
0
0
9,381
505
56
55
55565059,3810000
       Net Receivables 
26
2
784
2,334
4,391
1,220
2,564
5,259
5,2592,5641,2204,3912,334784226
       Inventory 
90
102
309
570
1,389
2,064
1,285
1,057
1,0571,2852,0641,38957030910290
       Other Current Assets 
66
372
214
473
586
655
799
548
54879965558647321437266
   > Long-term Assets 
926
1,616
1,946
4,859
4,389
4,794
6,188
5,774
5,7746,1884,7944,3894,8591,9461,616926
       Property Plant Equipment 
372
562
639
1,728
1,316
1,260
2,580
2,222
2,2222,5801,2601,3161,728639562372
       Intangible Assets 
554
809
1,183
3,079
3,026
3,483
3,554
2,387
2,3873,5543,4833,0263,0791,183809554
       Long-term Assets Other 
0
0
124
52
0
50
54
1,165
1,165545005212400
> Total Liabilities 
345
726
3,157
4,746
6,124
4,058
6,524
7,444
7,4446,5244,0586,1244,7463,157726345
   > Total Current Liabilities 
345
721
1,484
2,444
4,181
2,118
3,844
5,623
5,6233,8442,1184,1812,4441,484721345
       Short-term Debt 
0
408
9,998
279
222
229
380
403
4033802292222799,9984080
       Accounts payable 
241
485
1,153
1,532
1,379
1,613
2,919
2,068
2,0682,9191,6131,3791,5321,153485241
       Other Current Liabilities 
104
237
-9,889
99
105
151
140
2,749
2,74914015110599-9,889237104
   > Long-term Liabilities 
0
5
1,673
2,302
1,944
1,940
2,679
1,821
1,8212,6791,9401,9442,3021,67350
       Long term Debt Total 
0
0
0
286
116
110
962
0
0962110116286000
       Other Liabilities 
0
0
1,673
1,333
1,384
1,301
855
0
08551,3011,3841,3331,67300
       Deferred Long Term Liability 
0
0
379
1,288
1,371
1,485
1,369
0
01,3691,4851,3711,28837900
> Total Stockholder Equity
1,861
4,688
30,696
27,546
24,510
14,808
11,849
18,790
18,79011,84914,80824,51027,54630,6964,6881,861
   Common Stock
15,264
58,895
87,900
129,019
131,253
141,560
167,406
196,122
196,122167,406141,560131,253129,01987,90058,89515,264
   Retained Earnings -115,060-93,089-69,383-53,257-41,516-15,349-62-13,403
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 00000-41,44000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue33,414
Cost of Revenue-10,633
Gross Profit22,78122,781
 
Operating Income (+$)
Gross Profit22,781
Operating Expense-46,927
Operating Income-24,145-24,145
 
Operating Expense (+$)
Research Development8,571
Selling General Administrative5,610
Selling And Marketing Expenses20,165
Operating Expense46,92734,347
 
Net Interest Income (+$)
Interest Income468
Interest Expense-1,148
Other Finance Cost-364
Net Interest Income-317
 
Pretax Income (+$)
Operating Income-24,145
Net Interest Income-317
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-24,513-23,777
EBIT - interestExpense = -25,293
-24,513
-23,365
Interest Expense1,148
Earnings Before Interest and Taxes (EBIT)-24,145-23,365
Earnings Before Interest and Taxes (EBITDA)-22,468
 
After tax Income (+$)
Income Before Tax-24,513
Tax Provision-0
Net Income From Continuing Ops-16,271-24,513
Net Income-24,513
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses57,560
Total Other Income/Expenses Net-368317
 

Technical Analysis of Next Science Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Next Science Ltd. The general trend of Next Science Ltd is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Next Science Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Next Science Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.3 < 0.31 < 0.31.

The bearish price targets are: 0.275 > 0.195 > 0.18.

Tweet this
Next Science Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Next Science Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Next Science Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Next Science Ltd. The current macd is 0.01016985.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Next Science Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Next Science Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Next Science Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Next Science Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNext Science Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Next Science Ltd. The current adx is 18.01.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Next Science Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Next Science Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Next Science Ltd. The current sar is 0.24362099.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Next Science Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Next Science Ltd. The current rsi is 54.95. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Next Science Ltd Daily Relative Strength Index (RSI) ChartNext Science Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Next Science Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Next Science Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Next Science Ltd Daily Stochastic Oscillator ChartNext Science Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Next Science Ltd. The current cci is 72.51.

Next Science Ltd Daily Commodity Channel Index (CCI) ChartNext Science Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Next Science Ltd. The current cmo is 11.72.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Next Science Ltd Daily Chande Momentum Oscillator (CMO) ChartNext Science Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Next Science Ltd. The current willr is -28.57142857.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Next Science Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Next Science Ltd Daily Williams %R ChartNext Science Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Next Science Ltd.

Next Science Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Next Science Ltd. The current atr is 0.02464639.

Next Science Ltd Daily Average True Range (ATR) ChartNext Science Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Next Science Ltd. The current obv is -7,703,501.

Next Science Ltd Daily On-Balance Volume (OBV) ChartNext Science Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Next Science Ltd. The current mfi is 73.33.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Next Science Ltd Daily Money Flow Index (MFI) ChartNext Science Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Next Science Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Next Science Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Next Science Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.954
Ma 20Greater thanMa 500.245
Ma 50Greater thanMa 1000.254
Ma 100Greater thanMa 2000.309
OpenGreater thanClose0.285
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Next Science Ltd with someone you think should read this too:
  • Are you bullish or bearish on Next Science Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Next Science Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Next Science Ltd

I send you an email if I find something interesting about Next Science Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Next Science Ltd.

Receive notifications about Next Science Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.